Literature DB >> 23925888

Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.

Mohammad Murshid Alam1, Daniel T Leung, Marjahan Akhtar, Mohammad Nazim, Sarmin Akter, Taher Uddin, Farhana Khanam, Deena Al Mahbuba, Shaikh Meshbahuddin Ahmad, Taufiqur Rahman Bhuiyan, Stephen B Calderwood, Edward T Ryan, Firdausi Qadri.   

Abstract

Antibody avidity for antigens following disease or vaccination increases with affinity maturation and somatic hypermutation. In this study, we followed children and adults in Bangladesh for 1 year following oral cholera vaccination and measured the avidity of antibodies to the T cell-dependent antigen cholera toxin B subunit (CTB) and the T cell-independent antigen lipopolysaccharide (LPS) in comparison with responses in other immunological measurements. Children produced CTB-specific IgG and IgA antibodies of high avidity following vaccination, which persisted for several months; the magnitudes of responses were comparable to those seen in adult vaccinees. The avidity of LPS-specific IgG and IgA antibodies in vaccinees increased significantly shortly after the second dose of vaccine but waned rapidly to baseline levels thereafter. CTB-specific memory B cells were present for only a short time following vaccination, and we did not find significant memory B cell responses to LPS in any age group. For older children, there was a significant correlation between CTB-specific memory T cell responses after the second dose of vaccine and CTB-specific IgG antibody avidity indices over the subsequent year. These findings suggest that vaccination induces a longer-lasting increase in the avidity of antibodies to a T cell-dependent antigen than is measured by a memory B cell response to that antigen and that early memory T cell responses correlate well with the subsequent development of higher-avidity antibodies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925888      PMCID: PMC3807205          DOI: 10.1128/CVI.00341-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  39 in total

1.  Cholera vaccines: WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-03-26

Review 2.  Germinal-center organization and cellular dynamics.

Authors:  Christopher D C Allen; Takaharu Okada; Jason G Cyster
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

3.  CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation.

Authors:  Tanvir Ahmed; Mohammad Arifuzzaman; Michael Lebens; Firdausi Qadri; Anna Lundgren
Journal:  Vaccine       Date:  2009-10-17       Impact factor: 3.641

4.  Maturation of immunoglobulin G avidity after inactive gE deleted bovine herpesvirus type 1 (BHV-1) marker vaccination.

Authors:  Aykut Ozkul; Başak Demir; Taner Karaoğlu; Feray Alkan; Ender Dinçer; Taner Oncel; Ibrahim Burgu
Journal:  Viral Immunol       Date:  2008-03       Impact factor: 2.257

5.  Memory T-cell responses to Vibrio cholerae O1 infection.

Authors:  Ana A Weil; Mohammad Arifuzzaman; Taufiqur R Bhuiyan; Regina C LaRocque; Aaron M Harris; Emily A Kendall; Azim Hossain; Abdullah A Tarique; Alaullah Sheikh; Fahima Chowdhury; Ashraful I Khan; Farhan Murshed; Kenneth C Parker; Kalyan K Banerjee; Edward T Ryan; Jason B Harris; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

6.  Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.

Authors:  Elizabeth A Clutterbuck; Sarah Oh; Mainga Hamaluba; Sharon Westcar; Peter C L Beverley; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

7.  Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1.

Authors:  Channa R Jayasekera; Jason B Harris; Saruar Bhuiyan; Fahima Chowdhury; Ashraful I Khan; Abu S G Faruque; Regina C Larocque; Edward T Ryan; Rafi Ahmed; Firdausi Qadri; Stephen B Calderwood
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

8.  Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh.

Authors:  Aaron M Harris; M Saruar Bhuiyan; Fahima Chowdhury; Ashraful I Khan; Azim Hossain; Emily A Kendall; Atiqur Rahman; Regina C LaRocque; Jens Wrammert; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood; Jason B Harris
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

9.  Cytokine-secreting follicular T cells shape the antibody repertoire.

Authors:  R Lee Reinhardt; Hong-Erh Liang; Richard M Locksley
Journal:  Nat Immunol       Date:  2009-03-01       Impact factor: 25.606

10.  Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh.

Authors:  Jason B Harris; Regina C LaRocque; Fahima Chowdhury; Ashraful I Khan; Tanya Logvinenko; Abu S G Faruque; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  PLoS Negl Trop Dis       Date:  2008-04-09
View more
  10 in total

Review 1.  Cholera toxin B: one subunit with many pharmaceutical applications.

Authors:  Keegan J Baldauf; Joshua M Royal; Krystal Teasley Hamorsky; Nobuyuki Matoba
Journal:  Toxins (Basel)       Date:  2015-03-20       Impact factor: 4.546

2.  Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis.

Authors:  Anna Lena Lopez; Jacqueline Deen; Andrew S Azman; Francisco J Luquero; Suman Kanungo; Shanta Dutta; Lorenz von Seidlein; David A Sack
Journal:  Clin Infect Dis       Date:  2018-06-01       Impact factor: 9.079

3.  Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation.

Authors:  Samuel Cibulski; Ana Paula Muterle Varela; Thais Fumaco Teixeira; Martín Pablo Cancela; Patrícia Sesterheim; Diogo Onofre Souza; Paulo Michel Roehe; Fernando Silveira
Journal:  Front Immunol       Date:  2021-03-04       Impact factor: 7.561

Review 4.  Systemic, Mucosal, and Memory Immune Responses following Cholera.

Authors:  Edward T Ryan; Daniel T Leung; Owen Jensen; Ana A Weil; Taufiqur Rahman Bhuiyan; Ashraful Islam Khan; Fahima Chowdhury; Regina C LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Richelle C Charles
Journal:  Trop Med Infect Dis       Date:  2021-10-27

5.  Antibodies to neurofilament light as potential biomarkers in multiple sclerosis.

Authors:  Fabiola Puentes; Pascal Benkert; Sandra Amor; Jens Kuhle; Gavin Giovannoni
Journal:  BMJ Neurol Open       Date:  2021-11-11

6.  Profiling the Quality and Quantity of Naturally Induced Antibody Responses Against Pfs230 and Pfs48/45 Among Non-Febrile Children Living in Southern Ghana: A Longitudinal Study.

Authors:  Fermin K Broni; Festus K Acquah; Dorcas Obiri-Yeboah; Evans K Obboh; Esther Sarpong; Linda E Amoah
Journal:  Front Cell Infect Microbiol       Date:  2021-11-25       Impact factor: 5.293

7.  HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial.

Authors:  Sabrina H Tsang; John T Schiller; Carolina Porras; Troy J Kemp; Rolando Herrero; John Schussler; Monica S Sierra; Bernal Cortes; Allan Hildesheim; Douglas R Lowy; Ana Cecilia Rodríguez; Byron Romero; Nicolas Çuburu; Jaimie Z Shing; Ligia A Pinto; Joshua N Sampson; Aimée R Kreimer
Journal:  NPJ Vaccines       Date:  2022-03-29       Impact factor: 7.344

8.  Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial.

Authors:  Chidchamai Kewcharoenwong; Myint Myint Sein; Arnone Nithichanon; Aranya Khongmee; K Ryan Wessells; Guy-Marino Hinnouho; Maxwell A Barffour; Sengchanh Kounnavong; Sonja Y Hess; Charles B Stephensen; Ganjana Lertmemongkolchai
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

9.  Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.

Authors:  Brie Falkard; Richelle C Charles; Wilfredo R Matias; Leslie M Mayo-Smith; J Gregory Jerome; Evan S Offord; Peng Xu; Pavol Kováč; Edward T Ryan; Firdausi Qadri; Molly F Franke; Louise C Ivers; Jason B Harris
Journal:  PLoS Negl Trop Dis       Date:  2019-01-31

10.  Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination.

Authors:  Hayley A Thompson; Alexandra B Hogan; Patrick G T Walker; Michael T White; Aubrey J Cunnington; Christian F Ockenhouse; Azra C Ghani
Journal:  Vaccine       Date:  2020-10-09       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.